-
Cholera Vaccine Market Revenue Approximately US$ 9.2 Million by 2028, At CAGR 11.1% 2023-2028
11 Apr 2023 06:41 GMT
… Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics …
-
Worldwide Cholera Vaccines Industry to 2027 - Featuring Merck & Co, Pfizer, PharmaChoice Canada and Sanofi Among Others - ResearchAndMarkets.com
12 May 2022 12:45 GMT
… Pharma Inc.
Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
Emergent BioSolutions Inc.
Eubiologics …
-
Cholera Vaccines Market Research Report, Size, Share, Trends and Forecast to 2027
28 Jan 2022 13:53 GMT
… Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics …
-
uniQure Announces Leadership Team Appointments and Nominations to its Board of Directors
07 Aug 2017 11:00 GMT
… . McMillan held similar positions at AVANT Immunotherapeutics, Inc., and with Johnson Matthey …
-
Ellberger Named Chairman Of Celldex Therapeutics
08 Sep 2009 10:15 GMT
… March 2008 between Celldex and Avant Immunotherapeutics, Inc.<span id=…